Not too concerned about coverage that you are alluding to. There are tons of studies being done hopefully there will be some successes. Vaccines are 2021 events, hopefully we get one to pass all the tests. As for therapeutics Leronlimab’s success rate and unique MOA are now proven. No risks! Haven’t seen the kind of TV and print coverage for Leronlimab. It is exploding and it’s only been a matter of few weeks. Wait till the phase 2b/3 results hit the press, by month end - Cytodyn will carve it’s own place in the corona war!!